These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38926022)

  • 1. [First-line immunotherapy in non-small cell lung cancer diagnosed with brain metastases].
    Nigen B; Bodergat T; Vaugier L; Pons-Tostivint E
    Rev Mal Respir; 2024 Oct; 41(8):571-582. PubMed ID: 38926022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicity and time lapse between immunotherapy and stereotactic radiotherapy of brain metastases.
    Cabanie C; Biau J; Durando X; Mansard S; Molnar I; Chassin V; Verrelle P; Khalil T; Lapeyre M; Dupic G
    Cancer Radiother; 2021 Jul; 25(5):432-440. PubMed ID: 33836954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
    Singh C; Qian JM; Yu JB; Chiang VL
    J Neurosurg; 2020 Feb; 132(2):512-517. PubMed ID: 30771783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multimodal Treatment of Non-Small Cell Lung Cancer with Cerebral Metastases].
    Kudelin N; Bölükbas S; Schirren J
    Zentralbl Chir; 2015 Jun; 140(3):328-33. PubMed ID: 26114639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Immunotherapy and Stereotactic Radiotherapy Improves Neurologic Outcomes in Patients with Non-small-cell Lung Cancer Brain Metastases.
    Enright TL; Witt JS; Burr AR; Yadav P; Leal T; Baschnagel AM
    Clin Lung Cancer; 2021 Mar; 22(2):110-119. PubMed ID: 33281062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined treatment for non-small cell lung cancer and breast cancer patients with brain metastases with whole brain radiotherapy and temozolomide: a systematic review and meta-analysis.
    Tian J; Luo Y; Xiang J; Tang J
    J Neurooncol; 2017 Nov; 135(2):217-227. PubMed ID: 28726172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can upfront systemic chemotherapy replace stereotactic radiosurgery or whole brain radiotherapy in the treatment of non-small cell lung cancer patients with asymptomatic brain metastases?
    Kim KH; Lee J; Lee JI; Nam DH; Kong DS; Ahn YC; Park HC; Kwon OJ; Kim H; Chang MH; Yi SY; Ji SH; Park YH; Ahn JS; Park K; Ahn MJ
    Lung Cancer; 2010 May; 68(2):258-63. PubMed ID: 19592127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery with immunotherapy is associated with improved overall survival in patients with metastatic melanoma or non-small cell lung cancer: a National Cancer Database analysis.
    Jiang JM; Kabarriti R; Brodin NP; Ohri N; Guha C; Kalnicki S; Garg M
    Clin Transl Oncol; 2022 Jan; 24(1):104-111. PubMed ID: 34236616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging Trends in the Management of Brain Metastases from Non-small Cell Lung Cancer.
    Churilla TM; Weiss SE
    Curr Oncol Rep; 2018 May; 20(7):54. PubMed ID: 29736685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Combined Brain Radiotherapy and Immunotherapy in Non-Small-Cell Lung Cancer With Brain Metastases: A Systematic Review and Meta-Analysis.
    Yang Y; Deng L; Yang Y; Zhang T; Wu Y; Wang L; Bi N
    Clin Lung Cancer; 2022 Mar; 23(2):95-107. PubMed ID: 34284948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Brain Metastases in Non-Small-Cell Lung Cancer.
    Ernani V; Stinchcombe TE
    J Oncol Pract; 2019 Nov; 15(11):563-570. PubMed ID: 31715122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study.
    Moro-Sibilot D; Smit E; de Castro Carpeño J; Lesniewski-Kmak K; Aerts JG; Villatoro R; Kraaij K; Nacerddine K; Dyachkova Y; Smith KT; Girvan A; Visseren-Grul C; Schnabel PA
    Lung Cancer; 2015 Dec; 90(3):427-32. PubMed ID: 26791802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of up-front radiotherapy and TKI with TKI alone for NSCLC with brain metastases and EGFR mutation: A meta-analysis.
    Wang C; Lu X; Lyu Z; Bi N; Wang L
    Lung Cancer; 2018 Aug; 122():94-99. PubMed ID: 30032853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Efficacy and Safety of Immunotherapy on Non-Small Cell Lung Cancer Patients With Brain Metastases: A Systematic Review and Network Meta-Analysis.
    Lyu T; Sun B; Yang D; Zhao X; Wang R; Shu X; Li D; Chen H
    Clin Respir J; 2024 Aug; 18(8):e13823. PubMed ID: 39161997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent.
    Zhu J; Li R; Tiselius E; Roudi R; Teghararian O; Suo C; Song H
    Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011300. PubMed ID: 29247502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.
    Mulvenna P; Nankivell M; Barton R; Faivre-Finn C; Wilson P; McColl E; Moore B; Brisbane I; Ardron D; Holt T; Morgan S; Lee C; Waite K; Bayman N; Pugh C; Sydes B; Stephens R; Parmar MK; Langley RE
    Lancet; 2016 Oct; 388(10055):2004-2014. PubMed ID: 27604504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of CNS disease in ALK-positive non-small cell lung cancer: Is whole brain radiotherapy still needed?
    Wrona A
    Cancer Radiother; 2019 Sep; 23(5):432-438. PubMed ID: 31331844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
    Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
    Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic treatment of brain metastases from lung cancer].
    Barlesi F; Spano JP; Cortot AB; Carpentier AF; Robinet G; Besse B
    Cancer Radiother; 2015 Feb; 19(1):43-7. PubMed ID: 25656857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain metastases from non-small cell lung carcinoma: Changing concepts for improving patients' outcome.
    Rancoule C; Vallard A; Guy JB; Espenel S; Diao P; Chargari C; Magné N
    Crit Rev Oncol Hematol; 2017 Aug; 116():32-37. PubMed ID: 28693798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.